EcoDrugPlus

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSDLAG00005025249
Gene Symbol: ESRRGA
1 Cross references
203 Possible Orthologues:

Farnesyl Diphosphate Synthase (Farnesyl Pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransferase)

Ensembl ID : ENSDLAG00005011432
Gene Symbol: FDPS
1 Cross references
269 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSDLAG00005019138
Gene Symbol: FNTB
1 Cross references
203 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSDLAG00005020267
Gene Symbol: FGFR1A
1 Cross references
208 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSDLAG00005014660
Gene Symbol: FGFR2
1 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSDLAG00005023582
Gene Symbol: FGFR3
1 Cross references
191 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSDLAG00005002274
Gene Symbol: FLT1
1 Cross references
199 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSDLAG00005015701
Gene Symbol: FLT4
1 Cross references
197 Possible Orthologues:

Folate Receptor Gamma

Ensembl ID : ENSDLAG00005012198
Gene Symbol: FOLR3
1 Cross references
436 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSDLAG00005022892
Gene Symbol: FSHR
1 Cross references
201 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSDLAG00005009085
Gene Symbol: FRK
1 Cross references
217 Possible Orthologues:

Galactosidase, Alpha

Ensembl ID : ENSDLAG00005034424
Gene Symbol: GLA
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).